Scripps Research Translational Medicine Model

Business Profile

Core Value Proposition

Scripps Research Translational Medicine Model provides a nonprofit research framework that combines fundamental and translational science to accelerate the development of innovative medicines, with licensing revenues reinvested into ongoing research to sustain a self-renewing funding model.

Target Customer

Researchers, pharmaceutical and biotech partners, academic institutions, and funders seeking to translate discoveries into medicines and sustain long-term science.

Key Differentiator

A self-renewing nonprofit model that reinvests licensing revenues from medicines into research, coupled with an integrated structure of foundational science (Skaggs Graduate School) and translational medicine (Calibr-Skaggs Institute; Scripps Research Translational Institute) to accelerate drug discovery.

Implementation Timeline

Not specified

Pain Points

1Need to bridge gap between basic science and real-world medicines while maintaining sustainable funding
2Limited pathways to transform scientific discoveries into marketed therapies
3Scarce, stable funding for long-term, high-risk research

Key Features

1Integrated fundamental and translational research across chemistry, biology, and medicine
2Partnerships with pharmaceutical companies for development and licensing
3Dedicated translational institutes (Calibr-Skaggs Institute for Innovative Medicines; Scripps Research Translational Institute)
4Education and leadership development via the Skaggs Graduate School of Chemical and Biological Sciences
5Model that generates licensing revenues reinvested into research

Target Customer Industries

Client Results

1Accelerates development of new medicines and medical technologies
2Licensing revenues from medicines are reinvested into research, creating a self-sustaining funding stream
3Development of preventative approaches, diagnostics, and new medicines
4Training the next generation of scientific leaders

Competitive Advantages

1Self-renewing funding model from licensing revenues
2Integrated model spanning basic and translational science
3Access to high-profile translational institutes (Calibr-Skaggs, SRTI)
4Strong emphasis on training and leadership development

Key Benefits

1Faster translation of discoveries into real-world medicines

2Sustainable funding through licensing revenues

3Training and developing scientific leaders

4Access to translational medicine capabilities and partnerships

Additional Product Information

Product Description

A nonprofit research framework that combines world-class fundamental and translational science to accelerate the development of medicines, with licensing revenues reinvested into ongoing research to sustain breakthroughs.

Target Market

{"Pharma and biotech partners seeking to translate discoveries into medicines","Academic and medical research organizations","Health-focused funders and supporters"}

Unique Value Proposition

Nonprofit institute model that turns scientific discoveries into medicines and reinvests licensing revenues to support ongoing innovation, backed by integrated institutes and a strong education pipeline.

Technical Requirements

Not specified

Pricing Model

Not disclosed

Companies Solving Similar Problems

Based on matching: problems solved, key features, industries

Mindler Career Guidance Platform

Comprehensive career guidance and counselling services using advanced assessments and expert advice to help students discover and plan their ideal career paths.

Education

Career Counselling

Y Combinator

Y Combinator helps startups make something people want by providing early-stage funding, mentorship, and a strong network.

Technology

E-commerce

Design and Development Services

Umuzi Digital provides comprehensive design, product development, and strategic digital support at a fraction of the cost, enabling businesses to enhance their performance and grow.